1. Introduction {#sec0005}
===============

Bovine respiratory diseases (BRD) have etiologies of viruses, bacteria, and *Mycoplasma* spp. (Fulton,2008, 2009) Viruses included in BRD, either singly or in combination include bovine herpesvirus-1 (BoHV-1), parainfluenza −3 virus (PI3V), bovine viral diarrhea viruses (BVDV), bovine respiratory syncytial virus (BRSV), and bovine coronaviruses (BoCV)([@bib0040], [@bib0045], [@bib0025], [@bib0030], [@bib0035]). The bovine PI3V is a RNA virus in the genus *Respirovirus* in the family Paramyxoviridae ([@bib0005]). In North America both killed/inactivated and modified live virus (MLV) vaccines are used for control of these viruses ([@bib0010]). Clinicians seeking information on potential causative agents/etiologies often submit samples from cattle such as nasal swabs or blood samples from affected cattle and tissues from necropsy samples to the diagnostic laboratories. Samples may be tested by "traditional tests" including virus isolation for infectious virus or more often "modern tests", molecular tests including polymerase chain reaction (PCR) and in some cases, sequencing of the agent's genome ([@bib0035], [@bib0015]). Interpretation of such results is important for clinicians and the diagnostic laboratory. Viruses may appear to be similar based on the test used such as infectious viruses from cultures or these from the molecular tests that are homologous based on the product produced using primers. Also there is the dilemma of whether the virus identified is a field virus or a vaccine strain. A recent study utilized samples from cattle with BRD signs after processing with MLV vaccines administered ([@bib0035]). In that study there were isolates of BoHV-1, BVDV, and PI3V that utilized sequencing of the viral genome and found either field strains or vaccine strains. Thus it is important to be able to differentiate viral isolates of field or vaccine origin. Several PI3V strains in the U.S. have been examined using viral sequencing with three types identified, PI3VA, PI3VB, and PI3V C. ([@bib0070])

The study purposes were three-fold: (1) characterize PI3V strains in available commercial vaccines by molecular tests, (2) compare PI3V strains from field cases of BRD by molecular tests and to determine if the strain was related to MLV strains, and (3) using serums from calves given MLV vaccines containing PI3VA strains to determine antigenic variation when serums were tested in viral neutralization test with PI3VA and two PI3V C strains.

2. Materials and methods {#sec0010}
========================

2.1. Cattle groups {#sec0015}
------------------

Viruses from cattle in this study included 22 viruses from 4 different studies ([Table 1](#tbl0005){ref-type="table"} ) dated from 1999 until 2014. Study 1 were cattle from the Southeast (SE) region of the U.S. shipped to an experimental feed yard in New Mexico. ([@bib0020]) These cattle had not received PI3V vaccination prior to shipment. Study 2 included cattle from the SE U.S shipped to the Willard Sparks Experimental Feedyard at Oklahoma State University in 2009. Samples included both nasal swabs from cattle with BRD signs and samples collected from lungs at necropsy. These cattle had received a MLV vaccine containing PI3V at entry to the feed yard. Study 3 samples were from an Oklahoma feed yard from cattle with BRD signs and they had received a MLV vaccine at entry to the feed yard. The Study 4 included isolates from cattle using nasal swabs from cattle with BRD signs ([@bib0035]). For the Studies 2--4 the vaccine used in each particular study is listed in [Table 1](#tbl0005){ref-type="table"}.Table 1PI3V Isolates from BRD clinical cases.Table 1StudyYearIdentifcationCollection siteDays after processingMLV vaccine at procesingType by PCRStudy 11999OK P 100NS[a](#tblfn0005){ref-type="table-fn"}28No PI3V MLVPI3VAOK P 141NS28No PI3V MLVPI3VBOK P 147NS28No PI3V MLVPI3VAOK P 242NS33No PI3V MLVPI3VA  Study 22009OK 261 SPNS11Vax 1PI3VCOK 284 SP RLURight lung30Vax 1PI3VCOK 309 SP LLULeft lung18Vax 1PI3VCOK 453 SP RLURight lung24Vax 1PI3VCOK 467 SP RLURight lung17Vax 1PI3VCOK 643 SP LLULeft lung35Vax 1PI3VCOK 643 SP RLURight lung35Vax 1PI3VC  Study 32012OK PR 2 NSNS2Vax 2PI3VBOK PR 7 NSNS2Vax 2PI3VC  Study 42014OK P 5797NS12Vax 3PI3VCOK P 778NS20Vax 4PI3VCOK P 825NS20Vax 3PI3VCOK P 438NS19Vax 3PI3VCOK P 831NS20Vax 3PI3VCOK P 9054NSNAVax 3PI3VCOK P NM 64NS18Vax 5PI3VAOK 95806NS13Vax 6PI3VBOK 95524NS15Vax 6PI3VB[^1]

2.2. Viruses from field studies {#sec0020}
-------------------------------

The isolates from [Table 1](#tbl0005){ref-type="table"} from Studies 1 and 4 were grown in cell culture using MDBK or bovine turbinate monolayers and confirmed by direct fluorescent antibody tests and/or a gel based PCR test. ([@bib0035], [@bib0020]) Isolates from Studies 2 and 3 were grown in MDBK monolayers and confirmed as PI3V using gel based PCR test ([@bib0035])

2.3. Vaccines used in PCR and genomic characterization {#sec0025}
------------------------------------------------------

There were 7 different MLV vaccines available in the U.S. used for molecular testing and which are listed in [Table 2](#tbl0010){ref-type="table"} . ([@bib0010]) These included Vax 1, 2, 4,5,7,8, and 9. Vax 3 and Vax 6 represented vaccines among several different ones given to calves in Study 4, and did not contain PI3V.Table 2MLV vaccines with PI3VA.Table 2Vaccine no.VaccineVax 1BRD Shield ™Vax 2Pyramid ^®^ 5 MLVVax 3Pyramid ^®^ 3 MLVVax 4Titanium ™ 5 MLVVax 5BoviShield Gold 5 ^®^ MLVVax 6BoviShield IBR-BVD ^®^ MLVVax 7Vista ^®^ 5 SQ MLVVax 8Express ^®^ 5 MLVVax 9Arsenal ^®^ 4.1 MLV

2.4. Molecular tests {#sec0030}
--------------------

### 2.4.1. Genomic sequencing of PI3V strains {#sec0035}

Sequence analysis of BPI3V genomic RNAs was done as previously described ([@bib0065]) and as modified for use on the Illumina MiSeq ([@bib0055]). Sequences were assembled using the LaserGene NextGen suite (DNASTAR, Madison, WI). Comparison of sequences and generation of phylogenetic trees were done using MEGA 7.0 ([@bib0060]) .The viral sequence was a region of the viral nucleocapsid and had 1548 bases.

### 2.4.2. PI3V real time PCR {#sec0040}

PI3V isolates were genotyped by differential real-time PCR. Three primer/probe sets were used. The PI3V sets are illustrated in [Table 3](#tbl0015){ref-type="table"} . Because of the amount of genetic diversity in PI3V A viruses, a PI3V universal set was designed that detected all isolates. PCR primer and probe sets for type B and C were designed that were specific for the respective genotypes ([Table 3](#tbl0015){ref-type="table"}). The real time PCR primers were designed within the phosphoprotein (P) gene. PCR reactions were assembled using 0.4 μM of each primer and 0.2 μM probe in a 25 μl reaction using the QuantiFast Probe RT-PCR Kit (Qiagen, Inc., Valencia, CA). One microliter of cell culture fluid containing the virus was used as template. Cycling conditions were: 50 °C for 20 min, 95 °C for 5 min, then 40 cycles of 95 °C for 15 s and 62 °C for 30 s. Fluorescence was read following every cycle. The isolate was considered positive for a specific genotype if the Ct values were between 15 and 35. Above 35, the samples were considered negative.Table 3Real time PCR primers for determination of PI3V types.Table 3PrimerSequencePI3V U Forward[a](#tblfn0010){ref-type="table-fn"}AGA GCA CTC RAT TTA CAG ARA GG[b](#tblfn0015){ref-type="table-fn"}PI3V U ReverseGTA TCY GCA TTG TTN AGG ACA TT[c](#tblfn0020){ref-type="table-fn"}PI3V U ProbeAGA CAA GAG AGT TGT RTG TGT GGPI3V B ForwardTTG TGT GTG TGG CAA ATG TCPI3V B ReverseTTC TGT GTG ATT CGT CCA TTTPI3V B ProbeACT CCG ATC ATC AGG CCC GCPI3V C ForwardAAT AGG TGA CCC ACC CAA ACPI3V C ReverseCAG ATC ATC GAC ACT CCC ATA TCPI3V ProbeTTG AGA TGG AGC GGT CAA AGG[^2][^3][^4]

2.5. Serology {#sec0045}
-------------

The antigenic properties of two PI3V C strains were compared to PI3V A using each virus in a microtitration virus neutralization test (VNT) in 96-well MDBK monolayer assay. ([@bib0020]) The end point titer was the highest dilution of serum that inhibited viral CPE in both wells. The PI3V A strain was the SF4 strain obtained from the USDA National Veterinary Services Laboratory, Ames, IA. The virus titers of the PI3V B strains were insufficient for the VNT. The PI3V C viruses included OK P 9054 as PI3V C1 and OK P 438 as PI3V C2. Positive and negative control serums were included in each assay. The 97 serums were from post weaned calves bled prior to entering the feedlot and had been vaccinated with different MLV vaccines 4--6 weeks prior to collection. The differences in antibody levels to each virus in the VNT was analyzed with Fishers exact two sided test ([@bib0020]). The test was performed at the 0.05 level of significance.

3. Results {#sec0050}
==========

3.1. PI3V types in field isolates from BRD cases {#sec0055}
------------------------------------------------

There were 22 isolates from cattle with BRD signs ([Table 1](#tbl0005){ref-type="table"}). These were typed using the real time PCR test. There were 4 viruses that were PI3V A type, 4 were PI3V B type, and 14 were PI3V C. The 18 PI3V isolates (PI3V B and PI3V C) were different from the PI3V A in vaccine strains. As these isolates were tested only by PCR, the PI3V A isolates could not be differentiated from the PI3V A strains in MLV vaccines. There were 4 isolates in Study 1, three PI3V A and one PI3V B, and there were no PI3V MLV vaccines administered to these calves at entry to the study. The 1 PI3V B is definitely a field strain as the current MLV vaccines contain PI3V A.

In Study 2 there were 7 PI3V isolates and were all PI3V C type strains. The cattle had received a MLV vaccine containing the PI3V A type. Thus these isolates were field strains. Study 3 had 2 strains, one each of PI3V B and PI3V C. These cattle had received a MLV containing PI3V A prior at processing. Thus the two PI3V strains in this study were field strains.

Study 4 had 9 PI3V strains with 6 PI3V C, 2 PI3V B, and 1 PI3V A. These cattle had all received MLV vaccines with PI3V A at processing. The 8 isolates of PI3V C and PI3V B are field strains. The 1 PI3V A could not be determined as field or vaccine strain as sequencing was not performed.

In summary, the field strains of PI3V predominated (18/22, 81.8%) compared to those potentially with PI3V A in the MLV vaccines. However, if the 4 PI3V A had been sequenced they may have been different from PI3V A vaccine strains. This would be expected as the cattle had not received PI3V A vaccine at processing.

3.2. PI3V types in MLV vaccines and field strains detected by sequencing {#sec0060}
------------------------------------------------------------------------

The MLV vaccine strains of PI3V were subjected to sequencing of the viral genome region for the nucleocapsid using whole genome sequencing with 24 viruses sequenced. These included 7 MLV vaccine strains, (Vax 1,2,4,5,7,8, and 9), 7 reference strains from a prior study, (NM09,SF4,TVMD24,Q5592,TVMD15,12Q06, and TVMD16) ([@bib0070]), 8 strains that were typed by real time PCR, (OK PR 2, OK 261 SP, OK 309 SP, OK 284 SP, OK 643 SP RLU, OK 643 SP LLU, OK 467 SP, and OK 453 SP), and 2 without real time PCR testing, (OK P 9054 and OK P 7469). The results of the sequencing and types are included in [Fig. 1](#fig0005){ref-type="fig"} . The MLV vaccine strains were all PI3V A. In the dendogram, the Vax 8, 5, 2, and 7 appear identical as PI3V A type, although they share some, but not complete identity with Vax 4 and the NM09 strain. Also in the PI3V A group are Vax 1 and 9 which are identical to the SF4 strain. There is a reference strain, TVMD24 which is a PI3V A, however it is different from the other PI3V A strains.Fig. 1Dendogram of phylogenetic tree of PI3V types based on sequencing of nucleocapsid region of viral genome.Fig. 1

There was one of the field strains typed by PCR, OK PR 2 (PI3V B) which was identified as PI3V B as well. Reference strains Q5592 and TVMD15 were also identified as PI3V B by sequencing. There were 9 PI3V strains sequenced as PI3V C, and also included were reference strains 12Q061 and TVMD16.

3.3. PI3V types in cattle with BRD signs and MLV vaccinated {#sec0065}
-----------------------------------------------------------

There were 20 PI3V isolates in this study from cattle with prior MLV PI3 vaccination with PI3V A strains, eighteen from Studies 2, 3, and 4 listed in [Table 1](#tbl0005){ref-type="table"}, and two from [Fig. 1](#fig0005){ref-type="fig"} (OK P 9054 and OK P 7469). In this study, 19/20 (95.0%) were PI3V B or PI3V C strains. There was one strain OK NM P 64 as PI3V A strain detected by real time PCR, but not sequenced. Without sequencing, the field versus vaccine strain status could not be determined.

3.4. Serologic testing {#sec0070}
----------------------

There were 97 serums from calves receiving vaccines with PI3V A strains. The geometric mean titers and standard error of the mean (SE) are shown in [Table 4](#tbl0020){ref-type="table"} . The mean titer to the PI3V A SF 4 strain was 57.33, whereas the mean titers to PI3V C1 were 45.96 and to PI3V C2, 42.19. The titers in the serums of PI3V A vaccinated calves were higher to PI3V A than to both PI3V C1 and PI3V C2 with significance (\<0.05)Table 4Virus neutralizing antibody levels to PI3VA and PI3VC strains in serums from calves receiving PI3VA MLV vaccines.Table 4VirusMean and SE meanPI3VA57.33[a](#tblfn0025){ref-type="table-fn"} SE 11.35SF 4 strain  PI3VC 145.96[b](#tblfn0030){ref-type="table-fn"} SE 7.65OK P 9054  PI3VC 242.19[b](#tblfn0030){ref-type="table-fn"} SE 6.64OK P 438[^5][^6]

4. Discussion {#sec0075}
=============

This study provided additional information on the presence of PI3V types in both MLV vaccines and selected PI3V field strains as well as antigenic difference between PI3V A and other PI3V strains using serology. Using molecular tests including real time PCR and genomic sequencing of a region of the viral genome, nucleocapsid, and the PI3V strains could be differentiated into three types, PI3V A, PI3V B, and PI3V C. In this study the predominant PI3V type was other than PI3V A, and these included both PI3V B and C. Also with the vaccination history provided with the MLV vaccines given to the cattle, most of the isolates from cattle with BRD signs had been vaccinated with MLV PI3V A prior. It should be noted that cattle with the non MLV PI3V strains may have been exposed prior to transportation and commingling prior to vaccination. All of the commercial MLV available in the U.S, that were tested all were PI3V type A. using the viral sequencing with at least two groups each with identity to each other.

This study expands the knowledge of the characterization of viruses isolated from cattle with BRD signs with history of MLV vaccination. Cattle entering feedlots often have clinical signs of BRD within days of entering the feedlot. With samples submitted to the diagnostic laboratory and tested for viruses, resulting reports may indicate PI3V isolation from cultures or detection by molecular tests. Interpretation of those results is problematic as cell culture isolation or molecular tests will not differentiate field strains from the MLV vaccine strains. An earlier study ([@bib0035]) found that when BoHV-1, PI3V, and BVDV isolates from cattle with BRD signs/lesions were tested using viral genome sequencing, the strains could be separated into field versus vaccine strains. This study adds more specific information on the PI3V strains compared to the prior study ([@bib0035]) as the specific PI3V was identified (OK P 9054 and OK P 7469). This current study follows in line with a prior study where PI3V isolates in the U.S. include PI3V A strains along with PI3V B and PI3V C. ([@bib0070]) Several of those strains were included in reference strains in this study ([Fig. 1](#fig0005){ref-type="fig"}).

The current MLV vaccines in the U.S. with PI3V contain the PI3V A type. And it was noted that there are at least two groups of PI3V A vaccines with unique genomic patterns. The origins of the seed stock strain for each vaccine was not available to the authors in this study. With the finding of PI3V B and PI3V C types in the cattle population, the questions becomes, does the genomic variation affect the antigenic properties? In this study, there was evidence of antigenic variation with antibody titers from calves receiving PI3V A vaccines had lower antibody titers when PI3V C viruses were used in the VNT. These results are similar to a prior study in the U.S. ([@bib0070]) these findings are similar to another bovine virus, BVDV with antigenic properties varied among the genotypes of BVDV, BVDV1a, BVDV1b, and BVDV2a. ([@bib0050]) The efficacy of current MLV PI3V A vaccines should be evaluated using heterologous types such as PI3V B and PI3V C.

5. Conclusions {#sec0080}
==============

Points from this study include: (1) PI3V strains can be identified by molecular tests including real time PCR and viral sequencing with types A, B, and C identified, (2) commercial vaccines with MLV PI3V contain the PI3V A type, (3) PI3V strains from cattle receiving MLV vaccines at processing and later identified with BRD may have strains in the respiratory tract different from the MLV vaccine, and (4) the PI3V genomic differences may be manifested as antigenic differences.
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[^1]: NS-nasal swab.

[^2]: U- Universal primer for detection of all PI3V isolates.

[^3]: R-purine.

[^4]: N-any base.

[^5]: Those with different letters for the mean were significant different (\<0.05).

[^6]: SE = standard error of the mean.
